Rapid Micro Biosystems, Inc. reports results for the quarter ended June 30 - Earnings Summary

Rapid Micro Biosystems

07/08/2026 14:32

Rapid Micro Biosystems, Inc. RPID.OQ reported a quarterly adjusted loss of 27 cents​​ per share for the quarter ended June 30, identical to the same quarter last year.  The mean expectation of four analysts for the quarter was for a loss of 24 cents per share. Wall Street expected results to range from -26 cents to -23 cents per share.
Revenue rose 10.9% to $8.05 million from a year ago; analysts expected $7.88 million. 
Rapid Micro Biosystems, Inc.'s reported EPS for the quarter was a loss of 27 cents​.
The company reported a quarterly loss of $12.92 million.
Rapid Micro Biosystems, Inc. shares had risen by 20.2% this quarter and lost 28.3% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 4.3% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy" 
Wall Street's median 12-month price target for Rapid Micro Biosystems, Inc. is $7.00, about 70.3% above its last closing price of $2.08
This summary was machine generated from LSEG data August 7 at 01:32 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.24
-0.27
Missed
Mar. 31 2026 
-0.25
-0.31
Missed
Dec. 31 2025 
-0.22
-0.28
Missed
Sep. 30 2025 
-0.24
-0.26
Missed